Baldock Jennifer
Chief Admin & Dev Officer
Baldock Jennifer has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 16, 2026.
On the most recent filing, Baldock Jennifer is listed as Chief Admin & Dev Officer at Surgery Partners, Inc. Inside the rolling window, Baldock Jennifer reported no open-market purchases and 2 open-market sales totaling $214K in SGRY. The largest disclosed transaction in the window is a sale of 10,082 SGRY shares on Mar 6, 2026, worth $138K.
Companies traded
Other insiders at SGRY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$214K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Baldock Jennifer made?
Baldock Jennifer has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Baldock Jennifer trade?
Baldock Jennifer has filed SEC Form 4 disclosures for 1 company, including SGRY.
When was Baldock Jennifer's most recent SEC Form 4 filing?
Baldock Jennifer's most recent SEC Form 4 filing on Tracefour is dated Mar 16, 2026.
What is Baldock Jennifer's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Baldock Jennifer is listed as Chief Admin & Dev Officer.
What is Baldock Jennifer's total buy and sell value in the current window?
Inside the rolling retention window, Baldock Jennifer bought $0 and sold $214K based on SEC Form 4 filings.
What was Baldock Jennifer's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,082 SGRY shares on 2026-03-06, worth $138K, per SEC Form 4 filings.